SCHEMBL6175308

SCHEMBL6175308

CCN(CC)CCOC(=O)Nc1cc(CC2(C)NC(=O)N(c3ccc(OC(F)(F)F)cc3)C2=O)ccn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IGF1R P08069 5/20 0.39
MCHR1 Q99705 3/20 0.34
KDR P35968 3/20 0.33
FLT1 P17948 1/20 0.33
PPARD Q03181 3/20 0.33
PPARA Q07869 3/20 0.33
PPARG P37231 2/20 0.33
MAPT P10636 1/20 0.33
SLC5A1 P13866 1/20 0.33
CYP3A4 P08684 1/20 0.32
GAA P10253 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
AR P10275 1/20 0.32
NR1H2 P55055 1/20 0.32
NR1H3 Q13133 1/20 0.32
ABL1 P00519 1/20 0.32
EGFR P00533 1/20 0.32
PDGFRB P09619 1/20 0.32
KIT P10721 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6174016 0.92 IGF1R (0.41) IGF1RKDRFLT1PPARGMAPT
SCHEMBL6172735 0.90 IGF1R (0.42) IGF1RKDRFLT1MAPTSLC5A1
SCHEMBL6174444 0.89 IGF1R (0.52) IGF1RMCHR1
SCHEMBL6174414 0.88 IGF1R (0.38) IGF1RMAPTCYP2C9AR
SCHEMBL6173624 0.84 IGF1R (0.42) IGF1RKDRFLT1CYP3A4GAA
SCHEMBL6171765 0.84 IGF1R (0.41) IGF1RKDRFLT1SLC5A1CYP3A4
SCHEMBL2941442 0.84 IGF1R (0.58) IGF1RPPARDPPARAPPARG
SCHEMBL6174276 0.83 MAPK1 (0.34) IGF1RMCHR1KDRMAPTSLC5A1
SCHEMBL6172079 0.81 IGF1R (0.47) IGF1RCYP3A4GAACYP2C9CYP2C19
SCHEMBL6175090 0.81 IGF1R (0.54) IGF1RMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1599464-A2 NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS Aventis Pharma S.A. (FR) 2005-11-30 EP disclosed
WO-2004070050-A2 CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS AVENTIS PHARMA S.A. (FR) 2004-08-19 WO disclosed